[1] Naglik J,Albrecht A,Bader O,et al.Candida albicans proteinases and host/pathogen interactions[J].Cell Microbiol,2004,6(10):915-926. [2] Romani L.Immunity to fungal infections[J].Nat Rev Immunol,2011,11(4):275-288. [3] Safdar A,Hanna HA,Boktour M,et al.Impact of high-dose granulocyte transfusions in patients with cancer with candidemia:retrospective case-control analysis of 491 episodes of Candida species bloodstream infections[J].Cancer,2004,101(12):2859-2865. [4] Horn DL,Ostrosky-Zeichner L,Morris MI,et al.Factors related to survival and treatment success in invasive candidiasis or candidemia:a pooled analysis of two large,prospective,micafungin trials[J].Eur J Clin Microbiol Infect Dis,2010,29(2):223-229. [5] Kolaczkowska E,Kubes P.Neutrophil recruitment and function in health and inflammation[J].Nat Rev Immunol,2013,13(3):159-175. [6] Bertin J,Guo Y,Wang L,et al.CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B[J].J Biol Chem,2000,275(52):41082-41086. [7] Gross O,Gewies A,Finger K,et al.Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity[J].Nature,2006,442(7103):651-665. [8] Drewniak A,Gazendam RP,Tool AT,et al.Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency[J].Blood,2013,,121(13):2385-2392. [9] Lanternier F,Pathan S,Vincent QB,et al.Deep Dermatophytosis and Inherited CARD9 Deficiency[J].N Engl J Med,2013,369(18):1704-1714. [10] Lanternier F,Barbati E,Meinzer U,et al.Inherited CARD9 deficiency in two unrelated patients with invasive Exophiala infection[J].J Infect Dis,2014.pii:jiu412. [11] Wang X,Wang W,Lin Z,et al.CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficiencies[J].J Allergy Clin Immunol,2014,133(3):905-908. [12] Peltroche-Llacsahuanga H,Schnitzler N,Schmidt S,et al.Phagocytosis,oxidative burst,and killing of Candida dubliniensis and Candida albicans by human neutrophils[J].Fems Microbiol Lett,2000,191(1):151-155. [13] Luo S,Skerka C,Kurzai O,et al.Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans[J].Mol Immunol,2013,56(3):161-169. [14] Rambach G,Speth C.Complement in Candida albicans infections[J].Front Biosci (Elite Ed),2009,1:1-12. [15] Pereira HA,Hosking CS.The role of complement and antibody in opsonization and intracellular killing of Candida albicans[J].Clin Exp Immunol,1984,57(2):307-314. [16] Arnaout MA.Structure and function of the leukocyte adhesion molecules CD11/CD18[J].Blood,1990,75(5):1037-1050. [17] Gazendam RP,van Hamme JL,Tool AT,et al.Two independent killing mechanisms of Candida albicans by human neutrophils:evidence from innate immunity defects[J].Blood,2014,124(4):590-597. [18] Brown GD.Innate antifungal immunity:the key role of phagocytes[J].Annu Rev Immunol,2011,29:1-21. [19] Reeves EP,Lu H,Jacobs HL,et al.Killing activity of neutrophils is mediated through activation of proteases by K+ flux[J].Nature,2002,416(6878):291-297. [20] Drummond RA,Saijo S,Iwakura Y,et al.The role of Syk/CARD9 coupled C-type lectins in antifungal immunity[J].Eur J Immunol,2011,41(2):276-281. [21] Scapini P,Lapinet-Vera JA,Gasperini S,et al.The neutrophil as a cellular source of chemokines[J].Immunol Rev,2000,177:195-203. [22] Aukland K,Reed RK.Interstitial-lymphatic mechanisms in the control of extracellular fluid volume[J].Physiol Rev,1993,73(1):1-78. |